| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 06/17/2004 | WO2004044589A3 Diagnostics and therapeutics for diseases associated with human endothelial differentiation, sphingolipid g-protein-coupled receptor 3 (edg3) |
| 06/17/2004 | WO2004044231A3 Method for detecting intracellular cholesterol |
| 06/17/2004 | WO2004040312A3 Method for ngf assay for in vitro diagnosis of breast cancer and therapeutic use |
| 06/17/2004 | WO2004039600A3 Enzyme print humidification in a continuous process for manufacture of electrochemical sensors |
| 06/17/2004 | WO2004038411A3 Diagnostic and therapeutic use of ensadin-0289 gene and protein for neurodegenerative diseases |
| 06/17/2004 | WO2004038404A3 Method for optimizing therapeutic efficacy of nemorubicin |
| 06/17/2004 | WO2004038401A3 Biosensor having hematocrit and oxygen biases |
| 06/17/2004 | WO2004038364A3 In line test device and methods of use |
| 06/17/2004 | WO2004036175A3 Apparatus and process for sensing fluoro species in semiconductor processing systems |
| 06/17/2004 | WO2004034013A8 Genotoxicity analysis |
| 06/17/2004 | WO2004033677A3 Secreted acid phosphatase (sapm) is present only in pathogenic mycobacteria and expressed selectively at acidic ph |
| 06/17/2004 | WO2004032609A8 Systems and methods for rapidly and accurately identifying live eggs within a stream of eggs |
| 06/17/2004 | WO2004031913A3 Artificial intelligence for analyzing hypothetical models |
| 06/17/2004 | WO2004031767A3 Prevention of primary sjögren’s syndrome by ica69 deficiency |
| 06/17/2004 | WO2004031233A9 Novel chemokine-like polypeptides |
| 06/17/2004 | WO2004027421A3 Adp assay |
| 06/17/2004 | WO2004027379A3 Methods and devices for active bioassay |
| 06/17/2004 | WO2004025569A9 Tissue image analysis for cell classification and laser capture microdissection |
| 06/17/2004 | WO2004025262A3 Membrane-based assays |
| 06/17/2004 | WO2004023095A3 Continuous method of tracer generation for tagging natural gas |
| 06/17/2004 | WO2004023091A3 Localization of human cytomegalovirus nucleic acids and proteins in human cancer cells |
| 06/17/2004 | WO2004021000A9 Immunocapture-based measurements of mammalian pyruvate dehydrogenase complex |
| 06/17/2004 | WO2004020616A9 Method for diagnosing villous tissue atrophy of the small intestine |
| 06/17/2004 | WO2004018640A3 Preservation of rna quality and content in tissue sections during immunohistochemistry |
| 06/17/2004 | WO2004016156A3 Dynamic hepatic recycling glucose tolerance test |
| 06/17/2004 | WO2004014351A3 Use of cgrp antagonist compounds for treatment of psoriasis |
| 06/17/2004 | WO2004014220A3 Devices and methods for detecting amniotic fluid in vaginal secretions |
| 06/17/2004 | WO2004005888A3 Method for metal analysis and speciation and biosensor for effecting the method |
| 06/17/2004 | WO2003106660A3 Immunomodulation and effect on cell processes relating to serotonin family receptors and the blood-brain barrier |
| 06/17/2004 | WO2003105763A3 Prevention and/or treatment of inflammatory bowel disease using pyy or agonists thereof |
| 06/17/2004 | WO2003105660A3 Method for determining pathosis of biological objects |
| 06/17/2004 | WO2003098225A3 In vitro bioassay for determining the activity of glycoprotein hormones |
| 06/17/2004 | WO2003087993A3 Oligonucleotide probes for genosensor chips |
| 06/17/2004 | WO2003073351A3 Screening process |
| 06/17/2004 | WO2003071281A3 Estrogen receptor interaction with a transcription factor |
| 06/17/2004 | WO2003070162A3 Par-3 compounds for therapy and diagnosis and methods for using same |
| 06/17/2004 | WO2003068907A3 Method for the generation of proteins with new enzymatic function |
| 06/17/2004 | WO2003063770A9 Expression vectors encoding epitopes of target-associated antigens and methods for their design |
| 06/17/2004 | WO2003062791A3 Detection of single nucleotide polymorphisms using planar waveguides |
| 06/17/2004 | WO2003062402A3 Use of collections of binding sites for sample profiling and other applications |
| 06/17/2004 | WO2003060467A3 Method for analyzing effects of medical agents |
| 06/17/2004 | WO2003060227A3 Enzymatic degradation of cotton fibres: effect of protein cross-linking and the use of degradation to characterize fibers of plants of different genetic backgrounds |
| 06/17/2004 | WO2003058199A3 Arrays of microparticles and methods of preparation thereof |
| 06/17/2004 | WO2003057709A3 Method and reagent for the detection of proteins and peptides |
| 06/17/2004 | WO2003053997A3 Methods of increasing endogenous erythropoietin (epo) |
| 06/17/2004 | WO2003044528A3 Flow-controlled magnetic particle manipulation |
| 06/17/2004 | WO2003040064A3 Kits and methods for preparing cell samples optimized for dual staining |
| 06/17/2004 | WO2003039341A3 Methods and compositions to treat cardiovascular disease using 139, 258, 1261, 1486, 2398, 2414, 7660, 8587, 10183, 10550, 12680, 17921, 32248, 60489 or 93804 |
| 06/17/2004 | WO2003034073A3 Method and kit for monitoring recruitment of proteins to the intracellular domain of a receptor in intact cells |
| 06/17/2004 | WO2003032810A3 Treatment and diagnosis of insulin resistant states |
| 06/17/2004 | WO2003026566A3 Atlastin |
| 06/17/2004 | WO2003018632A3 Epitope regions of a thyrotrophin (tsh) receptor, uses thereof and antibodies thereto |
| 06/17/2004 | WO2003017992A3 Means for treatment of atherosclerosis |
| 06/17/2004 | WO2003010508A3 Assay for identifying anti-viral agents specific for protein-coated double-stranded dna viruses |
| 06/17/2004 | WO2003006673A3 A nucleic acid encoding a human junctional adhesion protein (jam3) |
| 06/17/2004 | WO2002103028A3 In silico screening for phenotype-associated expressed sequences |
| 06/17/2004 | WO2002086443A8 Methods of diagnosis of lung cancer, compositions and methods of screening for modulators of lung cancer |
| 06/17/2004 | WO2002086065A3 Induction of apoptosis by cellular stress |
| 06/17/2004 | WO2002079752A3 Detection of abnormal cells |
| 06/17/2004 | WO2002079419A3 Identifying and characterizing genes |
| 06/17/2004 | WO2002076248A3 Customized therapeutics and in situ diagnostics |
| 06/17/2004 | WO2002064015A3 Pin1 as a marker for prostate cancer |
| 06/17/2004 | US20040117867 Zebrafish animal models for clarifying gene function relationships in hyperproliferative disorders; antisense agents; RNA interference and tumor treatment therapies |
| 06/17/2004 | US20040117343 Methods for profiling and classifying tissue using a database that includes indices representative of a tissue population |
| 06/17/2004 | US20040117210 Networked remote patient monitoring with handheld devices |
| 06/17/2004 | US20040117209 Patient control of health-related data in a remote patient monitoring system |
| 06/17/2004 | US20040117208 Messaging to remote patients in a networked health-monitoring system |
| 06/17/2004 | US20040117207 Report generation in a networked health-monitoring system |
| 06/17/2004 | US20040117147 Monitoring automatic transmission fluid condition in real time |
| 06/17/2004 | US20040117130 System and method for improving the accuracy of DNA sequencing and error probability estimation through application of a mathematical model to the analysis of electropherograms |
| 06/17/2004 | US20040117129 Detection of biological warfare ; amlification, hybridizing nucleic acids |
| 06/17/2004 | US20040117128 Methods, computer software products and systems for gene expression cluster analysis |
| 06/17/2004 | US20040117127 Methods, computer software products and systems for clustering genes |
| 06/17/2004 | US20040117126 Method of assessing and managing risks associated with a pharmaceutical product |
| 06/17/2004 | US20040117117 System, method and computer program product for subsurface contamination detection and analysis |
| 06/17/2004 | US20040116689 can comprise DNA, RNA, PNA, or any combination or chimera thereof |
| 06/17/2004 | US20040116678 Cardiac hypertrophy factor and uses therefor |
| 06/17/2004 | US20040116672 Human sel-10 polypeptides and polynucleotides that encode them |
| 06/17/2004 | US20040116671 Novel polypeptides and nucleic acids encoding same |
| 06/17/2004 | US20040116670 Comprises polypeptides associated with cytoplasmic network of protein fibers that mediate cell shape, structure, and movement for diagnosis, treatment and prevention of cell proliferative, viral, neurological disorders |
| 06/17/2004 | US20040116669 Prostaglandin ep1 receptor |
| 06/17/2004 | US20040116662 Comprises viral glycoprotein fusion with glutathione s-tranferase (GST) or thioredoxin for use as diagnostic tool in screening blood products for retroviral infection |
| 06/17/2004 | US20040116661 Virulence peptides from attenuated microorganism for identifying microbiocides and developing vaccines which prevent infection; veterinary medicine |
| 06/17/2004 | US20040116659 Helicase inhibitors |
| 06/17/2004 | US20040116654 Isolated polypeptides; genetic engineering; quantitative analysis |
| 06/17/2004 | US20040116496 Asymmetric Disulfides and methods of using same |
| 06/17/2004 | US20040116405 Use of bicyclic esters or amides for the treatment of diseases responsive to enhanced potassium channel activity |
| 06/17/2004 | US20040116401 Diagnosis and treatment of human kidney diseases |
| 06/17/2004 | US20040116395 Combinations for the treatment of inflammatory disorders |
| 06/17/2004 | US20040116372 to decrease the number of cells which may accumulate in chronic inflammatory disease by enhancing apoptosis at the site of increased cell number via gene therapy |
| 06/17/2004 | US20040116350 Contacting the cell with an antioxidant, wherein the antioxidant is effective in reducing antibody mediated generation of superoxide or hydrogen peroxide in the cell |
| 06/17/2004 | US20040116349 Selecting patient displaying symptoms of heart disease; administering dose of growth factor protein formulation by oral inhalation; monitoring levels of CPK-MB; administering one or more additional doses of a second growth factor protein |
| 06/17/2004 | US20040116347 Contacting a cell comprising a compound, determining the effect of the compound upon the cell comprising the polypeptide or fragment thereof, thereby identifying a compound that modulates |
| 06/17/2004 | US20040116346 For use in therapy of anemia, as well as in other functions associated with assays for EPO-R, studying EPO and EPO-R function, purification of EPO-R |
| 06/17/2004 | US20040116342 Therapeutic use of a SMR1-peptide or a pharmaceutically active amount of SMR1-peptide, for the preparation of a therapeutic formulation for preventing or treating diseases wherein a modulation of activity of a membrane metallopeptidase is sought |
| 06/17/2004 | US20040116337 Soluble cyclic analogues of beta amyloid peptide |
| 06/17/2004 | US20040116333 Administering to the individual a multimeric compound that binds to at least two P-Selectin Glycoprotein Ligand 1 (PSGL-1) proteins on the surface of a T cell to induces a signal transduction pathway that results in the death of the T cell |
| 06/17/2004 | US20040115838 Multicompartment microfluidic device comprising elastomeric materials for monitoring receptor/ligand interactions; cell sorting; rational drug design and discovery |
| 06/17/2004 | US20040115837 Characterizing in vitro transfer of drug from non-aqueous liquid composition to aqueous medium; monitoring drug diffusion from sustained release dosage |
| 06/17/2004 | US20040115835 Using immunoglobilin A/G concentration in saliva to prognose, evaluate and monitor infection and chronic fatigue in horses; designing exercise programs |